Cargando…

2902. Pertussis Antibody Levels in Preterm Infants After Maternal Tdap Immunization During Pregnancy

BACKGROUND: Maternal immunization with tetanus, diphtheria, acellular pertussis vaccine (Tdap) in the third trimester reduces infant pertussis, but data are lacking on how this strategy impacts pertussis antibody levels in large cohorts of preterm infants METHODS: We collected paired maternal delive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Healy, C Mary, Rench, Marcia, Swaim, Laurie, Rajam, Gowrisankar, Havers, Fiona, Hariri, Susan, Schiffer, Jarad, Baker, Carol J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809112/ http://dx.doi.org/10.1093/ofid/ofz359.180

Ejemplares similares

1483. Maternal Tdap Vaccination During Pregnancy and Immune Response: A Comparison Between Infants Born to Mothers Primed with Acellular or Whole Cell Pertussis Vaccines
por: Havers, Fiona, et al.
Publicado: (2020)

Durability and Kinetics of Maternal Pertussis Antibodies in Infants of Mothers Immunized with Tdap During Pregnancy
por: Healy, C Mary, et al.
Publicado: (2017)

Effect of maternal Tdap on infant antibody response to a primary vaccination series with whole cell pertussis vaccine in São Paulo, Brazil
por: Vaz-de-Lima, Lourdes R.A., et al.
Publicado: (2021)

Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting
por: Ibrahim, Romesa, et al.
Publicado: (2018)

2902. Dalbavancin Use in Bone and Joint Infections
por: Sanikommu, Srivani, et al.
Publicado: (2023)

Effectiveness of Prenatal Tdap Immunization in the Prevention of Infant Pertussis in the United States
por: Becker-Dreps, Sylvia, et al.
Publicado: (2017)

1109 Knowledge and Attitudes of Pregnant Women Towards Recommendations for Immunization During Pregnancy
por: Healy, C. Mary, et al.
Publicado: (2014)

Cost-Effectiveness Analysis of Tdap in the Prevention of Pertussis in the Elderly
por: McGarry, Lisa J., et al.
Publicado: (2013)

Factors Influencing Maternal Antepartum Tdap Vaccination
por: Bernstein, Henry H., et al.
Publicado: (2022)

Perceptions of Tetanus-diphteria-acellular pertussis (Tdap) Vaccination among Korean Women of Childbearing Age
por: Kim, In Seon, et al.
Publicado: (2013)

Pharmacists’ Attitudes and Practices Regarding Tetanus, Diphtheria and Pertussis (Tdap) Vaccination in Pregnancy and Surrounding Newborns
por: Echtenkamp, Christine A, et al.
Publicado: (2018)

Improving Tdap maternal immunization rate in Saudi Arabia
por: Aldoosari, Agariad, et al.
Publicado: (2023)

Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model
por: Kang, Kyu Ri, et al.
Publicado: (2021)

2219. Evaluation of Medicare Claims to Assess Burden of Pertussis Disease in Persons Aged ≥65 Years
por: Havers, Fiona, et al.
Publicado: (2019)

Influenza and Tdap Vaccination Coverage Among Pregnant Women — United States, April 2018
por: Kahn, Katherine E., et al.
Publicado: (2018)

Factors Affecting the Implementation Process of Pertussis [Tdap] Immunization in Pregnant Women in an Italian Region: A Qualitative Study
por: Mazzilli, Sara, et al.
Publicado: (2020)

Tdap vaccination in pregnancy
por: Dalcin, Daniel, et al.
Publicado: (2021)

Influenza and Tdap Vaccination Coverage Among Pregnant Women — United States, April 2020
por: Razzaghi, Hilda, et al.
Publicado: (2020)

“When you are injected, the baby is protected:” Assessing the acceptability of a maternal Tdap vaccine based on mothers’ knowledge, attitudes, and beliefs of pertussis and vaccinations in Lusaka, Zambia
por: Larson Williams, Anna, et al.
Publicado: (2018)

Case-Control Study to Estimate the Association Between Tdap Vaccination During Pregnancy and Reduced Risk of Pertussis in Newborn Infants in Peru, 2019–2021
por: Juscamayta-López, Eduardo, et al.
Publicado: (2023)

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019
por: Havers, Fiona P., et al.
Publicado: (2020)

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults
por: Sirivichayakul, Chukiat, et al.
Publicado: (2016)

A study of acceptance and hesitation factors towards tetanus, diphtheria, and acellular pertussis (Tdap) and influenza vaccines during pregnancy
por: Quiles, Raquel, et al.
Publicado: (2023)

Cost-Effectiveness of Tdap Vaccination of Adults Aged ≥65 Years in the Prevention of Pertussis in the US: A Dynamic Model of Disease Transmission
por: McGarry, Lisa J., et al.
Publicado: (2014)

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults
por: Leroux-Roels, Geert, et al.
Publicado: (2017)

Blue Nevus Developing at a Combined Tetanus, Diphtheria, and Pertussis (Tdap) Vaccination Site: Case Report and Summary of Vaccine-Associated Cutaneous Lesions
por: Kim, Yoo Jung, et al.
Publicado: (2019)

Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study
por: Walls, Tony, et al.
Publicado: (2016)

Tdap vaccination during pregnancy and risk of chorioamnionitis and related infant outcomes
por: Greenberg, Victoria, et al.
Publicado: (2023)

Flu and Tdap Maternal Immunization Hesitancy in Times of COVID-19: An Italian Survey on Multiethnic Sample
por: Cavaliere, Anna Franca, et al.
Publicado: (2021)

Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose
por: Halperin, Scott A, et al.
Publicado: (2018)

Influence of Timing of Maternal Pertussis Immunization on the Avidity of Transferred Antibodies in Term and Preterm Neonates
por: Sartoretti, Julie, et al.
Publicado: (2023)

971 Clinical Spectrum of Group B Streptococcol Cellulitis-Adenitis Syndrome
por: Pretorius, Christopher C., et al.
Publicado: (2014)

106. High Maternal Tdap Vaccine Uptake During Early Part of Vaccination Window: Implications for Future Maternal Vaccines
por: Law, Amy W, et al.
Publicado: (2022)

The effect of maternal pertussis vaccination on the epidemiology of pertussis in Spain
por: Godoy, Pere, et al.
Publicado: (2022)

The effect of maternal pertussis vaccination on the epidemiology of pertussis in Spain
por: Godoy, Pere, et al.
Publicado: (2022)

Vital Signs: Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants — United States
por: Lindley, Megan C., et al.
Publicado: (2019)

Combined Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccine-Related Erythema Nodosum: Case Report and Review of Vaccine-Associated Erythema Nodosum
por: Cohen, Philip R.
Publicado: (2013)

Preliminary study on the immunogenicity of a newly developed GCC Tdap vaccine and its protection efficacy against Bordetella pertussis in a murine intranasal challenge model
por: Han, Seung Beom, et al.
Publicado: (2015)

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012
por: Sawyer, Mark, et al.
Publicado: (2013)

Safety and use of tetanus-diphtheria-acellular pertussis-5 (Tdap5) vaccine during pregnancy: findings from 11 years of reporting to a pregnancy registry
por: Switzer, Charlotte, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i21c17uoqf9e5v5l9sj3ru06c6